Alzheimer's drug trial shows 'evidence of sustained improvement'

by University of AberdeenRelationship between steady-state plasma levels of hydromethylthionine and decline on the ADAS-Cog11scale over 65 weeks in 566 participants receiving hydromethylthi

Updated on: April 16,2024 18

Alzheimer's drug trial shows 'evidence of sustained improvement'

by University of AberdeenRelationship between steady-state plasma levels of hydromethylthionine and decline on the ADAS-Cog11scale over 65 weeks in 566 participants receiving hydromethylthi

Updated on:April 16,2024 18

Advances along the gut-liver-brain axis in Alzheimer's disease

by Alzheimer's AssociationPET scan of a human brain with Alzheimer's disease. Credit: public domainFour new studies reported at the Alzheimer's Association International Conference (AAIC)

Updated on: April 16,2024 19

Advances along the gut-liver-brain axis in Alzheimer's disease

by Alzheimer's AssociationPET scan of a human brain with Alzheimer's disease. Credit: public domainFour new studies reported at the Alzheimer's Association International Conference (AAIC)

Updated on:April 16,2024 19

Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

by Steve Macfarlane,The ConversationCredit: AI-generated imageTrial results of a new drug to treat Alzheimer's disease, donanemab, shows it canslow cognitive declineby 35%. The d

Updated on: April 16,2024 18

Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

by Steve Macfarlane,The ConversationCredit: AI-generated imageTrial results of a new drug to treat Alzheimer's disease, donanemab, shows it canslow cognitive declineby 35%. The d

Updated on:April 16,2024 18

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024 12

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024 12

Alzheimer research: Noise-inducing neurons shut down memories

by German Center for Neurodegenerative DiseasesCredit: Public DomainNeurons that are responsible for new experiences interfere with the signals of neurons that contain memories and thereby distur

Updated on: April 16,2024 10

Alzheimer research: Noise-inducing neurons shut down memories

by German Center for Neurodegenerative DiseasesCredit: Public DomainNeurons that are responsible for new experiences interfere with the signals of neurons that contain memories and thereby distur

Updated on:April 16,2024 10

Immune system dysfunction may occur early in Alzheimer's disease

by CU Anschutz Medical CampusPET scan of a human brain with Alzheimer's disease. Credit: public domainAn association between inflammation biomarkers in both blood plasma and cerebrospinal flu

Updated on: April 16,2024 10

Immune system dysfunction may occur early in Alzheimer's disease

by CU Anschutz Medical CampusPET scan of a human brain with Alzheimer's disease. Credit: public domainAn association between inflammation biomarkers in both blood plasma and cerebrospinal flu

Updated on:April 16,2024 10

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease

Updated on: April 16,2024 10

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease

Updated on:April 16,2024 10

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that

Updated on: April 16,2024 10

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that

Updated on:April 16,2024 10

Drug target for Alzheimer's disease has dual action

by Queensland Brain InstituteCredit: Queensland Brain InstituteResearchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervou

Updated on: April 16,2024 11

Drug target for Alzheimer's disease has dual action

by Queensland Brain InstituteCredit: Queensland Brain InstituteResearchers have discovered a potential drug target for Alzheimer's disease—an enzyme which has effects on both the immune and nervou

Updated on:April 16,2024 11

Alzheimer's researchers study drug efficacy in early stages of disease

by Indiana University School of MedicineCredit: Pixabay/CC0 Public DomainMost drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from

Updated on: April 16,2024 18

Alzheimer's researchers study drug efficacy in early stages of disease

by Indiana University School of MedicineCredit: Pixabay/CC0 Public DomainMost drugs developed to treat Alzheimer's disease have for years been ineffective in clinical trials. Researchers from

Updated on:April 16,2024 18

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on: April 16,2024 14

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on:April 16,2024 14

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused

Updated on: April 16,2024 11

Alzheimer's researchers find clues to toxic forms of amyloid beta

by University of California - Santa CruzDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Much of the research on Alzheimer's disease has focused

Updated on:April 16,2024 11